fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Thank You, Linda

It is with a heavy heart that the American Brain Tumor Association (ABTA) announces the recent passing of ABTA co-founder Linda Gene Goldstein.

Susan Netchin Kramer and Linda Gene Goldstein founded the ABTA in Chicago in 1973. After Susan’s daughter, Stephanie, was diagnosed with a brain tumor, Susan was determined to find a cure to save her little girl. Her path crossed with Linda, whose daughter, Micki Rae Shanoff, just passed from a brain tumor.

“Mom took tremendous pride in her work for the ABTA. I know how much it meant that the unspeakable pain she suffered could be
used to help others.”

From the depths of great despair, these women joined forces to establish a national organization dedicated to accelerating research and providing patient resources.

“With Susan Kramer, mom co-founded the ABTA after losing my beautiful 6 ½-year-old sister, Micki Rae Shanoff, to a glioblastoma multiforme (GBM) of the pons,” said Linda’s son, TJ Shanoff. “Mom took tremendous pride in her work for the ABTA. I know how much it meant to her that the immense, unspeakable pain she suffered could be used to help others.”

With Linda’s dedication in the earlier years of the ABTA, Susan continued to shape and expand the organization, which has raised over $32 million for brain tumor research and provides best-in-class support services and information.

“We are emboldened by this loss to continue our mission to help ensure not one life is lost to a brain tumor,” said Ralph DeVitto, president and CEO of the American Brain Tumor Association.

Read more about the founding of the American Brain Tumor Association.

 

Susan Kramer with Linda Gene Goldstein at the ABTA 40th Anniversary celebration.


 

Make a Difference TOday

Your generosity fuels progress. The American Brain Tumor Association has already invested over $35 million in life-changing brain tumor research, leading to breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma.

Through our Meet Hope Head On campaign, we’re not just funding critical research—we’re also providing free resources and support to patients and caregivers navigating the challenges of a brain tumor diagnosis.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.